Chiropractic Rehabilitation Tips for Systemic Inflammation

Find out how chiropractic rehabilitation for systemic inflammation can aid your recovery and promote overall physical well-being.

Abstract

In this educational post, I walk you through a clear, evidence-based journey into systemic inflammation: what it is, how it sustains chronic disease, and how we can pragmatically address it using an integrative, multidisciplinary model. Drawing on modern immunology and translational research, I explain the roles of macrophage phenotypes (M1 vs. M2), microglial activation in the brain, and the regulatory circuits governed by T cells and the thymus. I analyze how chronic low-grade inflammation—often termed “inflammaging”—connects metabolic, cardiovascular, neurologic, and oncologic risk, and I explore how targeted, lifestyle-first care combined with integrative chiropractic, functional medicine, and medical oversight can recalibrate immune-homeostatic control.

This post presents updated findings from leading researchers using rigorous, evidence-based methods; it also illustrates how these insights translate to patient care at our clinic. I introduce our multidisciplinary leadership: Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), who has over 40 years of internal medicine practice, serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, working alongside me, Dr. Alex Jimenez, DC. Together, we integrate chiropractic care, medical supervision, functional medicine, personal injury care, and rehabilitative services to produce accountable outcomes and personalized care plans.

I also discuss clinical protocols that help transition the immune system from a chronic M1 pro-inflammatory bias toward a balanced, reparative M2 phenotype while strengthening regulatory T cell function and autonomic stability. You’ll find detailed, plain-language explanations of physiologic mechanisms, reasons for each intervention, and how we incorporate diagnostics, safety, and staged care. Finally, I lay out a roadmap for patients, families, and clinicians seeking safe, effective strategies to reduce systemic inflammation and restore function with collaborative care.

Integrative Care Overview: How We Work As A Team In El Paso, Texas

• Medical Director: Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine) (NPI #1164426749, Texas MD License #J2933), serves as our Medical Director and Collaborative Physician at Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic.
• Chiropractic and Functional Medicine: I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, lead integrative chiropractic and functional medicine services, with a focus on musculoskeletal health, neuroimmune regulation, and evidence-based lifestyle interventions.
• Multidisciplinary Environment: We blend chiropractic adjustments, therapeutic exercise, neuromuscular re-education, functional lab analysis, medical supervision, and targeted rehabilitation in a single, coordinated plan.
• Safety and Scope: Dr. Cardenas provides medical oversight, ensures safety for patients with complex conditions, supervises pharmacologic considerations, and co-manages diagnostics for systemic inflammation. I orchestrate musculoskeletal and autonomic interventions, guide nutrition and movement strategies, and coordinate personal injury and rehab pathways.

Our mission is to combine modern immunology with biomechanical and lifestyle science to deliver integrative care that addresses root drivers of inflammation while improving function and quality of life.

Understanding Systemic Inflammation In First-Person: What I Explain To My Patients

When the immune system’s off-switch fails, we see systemic inflammation—a whole-body state where macrophages remain locked in a pro-inflammatory M1 mode. In this state, innate immune cells release TNF-alpha, IL-6, and other cytokines into circulation. Over time, this persistent signaling creates a biochemical environment that strains the endothelium, perturbs metabolic homeostasis, destabilizes the autonomic nervous system, and fuels neuroinflammation.

I remind patients that inflammation’s purpose is to protect and repair. The problem isn’t inflammation per se; it’s the failure to complete the cycle—switching from the initial “contain and clear” phase to the “repair and resolve” phase. This shift largely depends on how macrophages move along their functional spectrum: from M1 (pro-inflammatory) to M2 (pro-resolving) states. The longer we remain trapped in M1, the more tissues experience oxidative stress, mitochondrial strain, and microvascular dysfunction.

In our clinic, we intentionally design interventions that help the body transition toward resolution: enabling M2-like activity, supporting regulatory T cells (Tregs), and stabilizing autonomic tone. This is not a single-pill solution; it’s a coordinated, reproducible process backed by evidence, clinical observation, and multidimensional care.

The Macrophage Spectrum: M1 And M2 Explained In Simple Terms

• M1 macrophages: These cells are primed for threat response. They produce cytokines including TNF-α, IL-6, IL-1β, as well as reactive oxygen species (ROS). Think of M1 as the “contain and neutralize” phase.
• M2 macrophages: These cells favor tissue cleanup, remodeling, and resolution. They produce IL-10, TGF-β, and arginase-1; coordinate debris clearance; support matrix remodeling; and help restore balance.

The core issue in chronic disease is not that M1 exists—it’s that the pivot back to M2-mediated resolution fails. Factors like metabolic endotoxemia, persistent micro-injury, psychosocial stress, sleep disruption, and dysautonomia can prevent that transition. The body remains stuck in a low-grade “threat state,” amplifying cytokines across multiple tissues simultaneously.

Why Persistent M1 Bias Impacts Every Organ System

When M1 signaling predominates across many organs concurrently—adipose tissue, liver, kidneys, endothelium, and notably the brain—we see common patterns:

• Adipose: Adipose tissue macrophages skew toward M1 under caloric excess and hypoxia within expanding fat depots, promoting insulin resistance and adipokine imbalance.
• Liver: Kupffer cells (liver-resident macrophages) amplify inflammatory signaling, impair insulin signaling, and contribute to NAFLD/NASH
• Vasculature: Endothelial cells exposed to cytokines express adhesion molecules, inviting leukocyte adhesion and fueling atherogenesis.
• Kidneys: Chronic cytokine exposure contributes to glomerular and tubulointerstitial damage
• Brain: Microglia, the brain’s resident macrophages, shift toward chronic activation, impair synaptic plasticity, and release ROS. This environment suppresses BDNF and undermines neuroplasticity.

This is a systems problem: a single maladaptive program executed across multiple tissues, producing multiple disease expressions. Mainstream epidemiology shows that markers like IL-6 and TNF-alpha correlate with long-term risk, underscoring the need for approaches that resolve upstream immune dysregulation.

Microglia And Neuroinflammation: One Mechanism, Many Presentations

Within the central nervous system, microglia monitor and maintain synaptic health. In a chronic M1-like activation state, they:

• Release pro-inflammatory cytokines and ROS.
• Suppress BDNF, reducing synaptic maintenance and growth.
• Impair neuroplasticity, contributing to cognitive decline, mood disturbances, and neurodegenerative trajectories.

While diagnoses such as Alzheimer’s disease, Parkinson’s disease, vascular dementia, and even depressive syndromes manifest differently, they frequently share the neuroinflammatory backbone. The practical implication is that stabilizing systemic inflammation and nurturing neurotrophic support can meaningfully alter brain-related outcomes, particularly when introduced early and maintained consistently.

T Cell Regulation, The Thymus, And Immune Quality Control

The thymus is the academy where T cells learn self from non-self. Through positive and negative selection, it shapes a T cell repertoire capable of defending without self-destruction. When this quality control falters—due to age, stress, infections, or metabolic stressors—self-reactive T cells can slip through. In contrast, regulatory T cells (Tregs) may be insufficient to maintain tolerance.

In our practice, we do not oversimplify complex autoimmunity, and we avoid absolute claims that “autoimmune disease does not exist.” Autoimmune conditions are well-characterized clinically and scientifically; however, an upstream failure in immune regulation often precedes the diversity of autoimmune phenotypes. Our emphasis is on improving regulatory balance: fostering Treg support, reducing antigenic load, moderating inflammatory triggers, and stabilizing the neuroendocrine-immune axis.

Why Target The Upstream Loop: From Downstream Symptom Control To Regulatory Repair

Pharmaceuticals such as statins, metformin, SSRIs, or biologics can provide critical symptom relief and risk reduction for specific conditions and are often life-saving. But symptom-directed therapies do not always address the upstream circuitry that sustains chronic inflammation. Our approach is to maintain respect for the necessary role of conventional therapies while simultaneously addressing:

• Immune regulation (e.g., Treg function, antigenic load reduction)
• Macrophage polarization (facilitating M2 resolution pathways)
• Neuroimmune-autonomic balance (improving vagal tone, HRV)
• Metabolic resilience (insulin sensitivity, mitochondrial support)
• Vascular health (endothelial function, microcirculation)

This dual-path strategy enhances safety, honors patient-specific needs, and evolves as clinical data and patient response clarify the best path forward.

Unlocking the Secrets of Inflammation: Integrative Medicine Approach- Video

Our Integrative Chiropractic-Medical Model In Practice

• Medical Direction (Dr. Cardenas, MD): Oversees diagnostics, ensures safety, manages comorbidities, evaluates medication-lifestyle interactions, and coordinates care with external specialists when necessary.
• Chiropractic and Functional Care (Dr. Jimenez, DC, APRN): Assesses biomechanics, autonomic tone, pain generators, movement patterns, and lifestyle drivers of inflammation. Implements chiropractic adjustments, neuromuscular re-education, therapeutic exercise, stress modulation, and targeted nutrition strategies.
• Rehabilitation: Customized phased rehabilitation programs addressing core stability, gait mechanics, tissue loading, and progressive strength.
• Personal Injury: Acute and post-acute care following injuries with coordinated medical-chiropractic oversight, imaging, documentation, and tailored return-to-function protocols.
• Functional Testing: In selected cases, use of inflammatory markers, cardiometabolic panels, and autonomic assessments to calibrate treatment.

By coordinating each of these pillars under one roof, we streamline care, improve adherence, and align interventions with objective outcomes.

Evidence-Based Context: Systemic Inflammation And Health Outcomes

• Elevated IL-6 and TNF-alpha are consistently associated with all-cause mortality and cardiovascular risk across prospective cohorts and meta-analyses (Ridker et al., 2017; Emerging Risk Factors Collaboration, 2010; Kaptoge et al., 2014). Evidence shows these cytokines are independent predictors, reinforcing the need to address upstream inflammation beyond single-organ management (Kaptoge et al., 2010; Emerging Risk Factors Collaboration, 2012).
• Chronic low-grade inflammation—often labeled inflammaging—plays a central role in cardiometabolic disease, neurodegeneration, and cancer risk (Franceschi et al., 2018; Furman et al., 2019; Calder, 2020).
• Neuroinflammation is tightly linked to neurodegenerative pathways, with microglial activation and impaired BDNF signaling linked to synaptic dysfunction and cognitive decline (Heneka et al., 2015; Salter & Stevens, 2017; Schwartz & Baruch, 2014).
• T cell dysregulation and impaired tolerance mechanisms underpin many organ-specific immune disorders; supporting regulatory pathways is central to immune balance (Sakaguchi et al., 2008; Josefowicz et al., 2012).

We integrate these findings in patient care through layered, pragmatic steps that respect patient safety and real-world constraints.

Clinical Observations From My Practice

I publish observations on complex pain, metabolic stress, autonomic dysregulation, and rehabilitation outcomes at WellnessDoctorRx and via professional updates on LinkedIn. Across patients with chronic pain, post-injury recovery, and cardiometabolic risk, I consistently see that:

• Autonomic modulation—particularly improving vagal tone—reduces pain perception, stabilizes HRV, and aids sleep.
• Mechanical integrity—through adjustments and corrective exercise—lowers nociceptive drive and reduces systemic inflammatory markers in selected cases.
• Nutritional recalibration—emphasizing whole foods, adequate protein, omega-3s, polyphenols, fiber, and glycemic control—complements mechanical and autonomic steps by dampening postprandial inflammation.
• Load management—graduated, measurable strengthening—protects tissues from reinjury and sustains M2-biased resolution during remodeling.

References to these themes can be found within my clinical communications:

• WellnessDoctorRx: https://wellnessdoctorrx.com/
• LinkedIn: https://www.linkedin.com/in/dralexjimenez/

The Four Domains Of Inflammation Resolution We Target

• Biochemical Terrain
  • Goal: Reduce inflammatory load, stabilize insulin sensitivity, support mitochondrial function, and provide precursors for pro-resolving mediators.
  • Tools: Nutrition interventions, omega-3 fatty acids, fiber, polyphenols, targeted micronutrients, glycemic control, circadian eating windows, hydration, and in medically supervised cases, adjunctive therapies.

• Neuroautonomic Stability

• • Goal: Improve vagal tone and heart rate variability (HRV), regulate HPA axis, and reduce sympathetic overdrive.
  • Tools: Breathing protocols, biofeedback, gentle chiropractic adjustments that reduce nociceptive drive, sleep hygiene interventions, stress skills training, cold/heat exposure with caution.

• Mechanical Integrity

• • Goal: Address pain generators, joint dysfunction, and kinetic chain inefficiencies that drive persistent nociception and local inflammation.
  • Tools: Integrative chiropractic adjustments, soft tissue mobilization, proprioceptive training, corrective exercise, progressive load training, gait retraining, and tendon-bone-muscle synergy work.

• Immune Regulation

• • Goal: Encourage balanced macrophage polarization and strengthen Treg-mediated tolerance.
  • Tools: Sleep optimization, nutrition that supports SCFA production, physical activity, stress reduction, careful management of environmental antigen burden, and in select cases under medical guidance, immune-modulating therapies.

These domains interlock. Progress in one domain supports the others, creating a virtuous cycle that transitions the body from threat state to repair state.

Physiologic Underpinnings: Why Each Intervention Matters

• Omega-3 Fatty Acids: EPA and DHA can transform into specialized pro-resolving mediators (SPMs) like resolvins and protectins, which encourage resolution without immunosuppression (Serhan & Levy, 2018). Clinically, patients with elevated hs-CRP and low omega-3 status often benefit from dietary fish intake and supplementation, particularly when combined with fiber and polyphenols.
• Fiber and SCFAs: Short-chain fatty acids like butyrate, produced by microbial fermentation of fiber, support Treg differentiation and intestinal barrier integrity (Koh et al., 2016). Improved barrier function reduces metabolic endotoxemia, lowering systemic cytokine tone.
• Sleep: Sleep loss elevates IL-6 and TNF-alpha, impairs insulin sensitivity, and destabilizes autonomic balance (Irwin, 2015). Sleep restoration is fundamental for T cell function and microglial homeostasis.
• Movement: Moderate-intensity exercise increases IL-10, reduces adipose macrophage M1 polarity, and improves insulin signaling (Gleeson et al., 2011). Progressive resistance training supports myokines that confer anti-inflammatory signaling.
• Chiropractic Adjustments: Targeted spinal and joint care can reduce nociceptive input, influencing central sensitization and sympathetic tone. Improved motion reduces localized inflammatory mediators and facilitates more efficient neuromuscular control.
• Breathing and HRV Training: Slow, diaphragmatic breathing enhances vagal tone, shifting autonomic balance toward parasympathetic dominance, thereby moderating inflammatory output via the cholinergic anti-inflammatory pathway (Tracey, 2002).
• Glycemic Control: Postprandial spikes fuel oxidative stress and endothelial activation; blunted glycemic excursions reduce NF-κB activation and cytokine release (Esposito et al., 2002).
• Polyphenols: Compounds like curcumin, quercetin, and catechins modulate NF-κB and Nrf2 pathways, supporting antioxidant defenses and attenuating cytokine excess (Calder, 2020; Panahi et al., 2016).

Each element is small on its own, but collectively they produce a measurable physiological pivot—lower baseline inflammatory tone, better metabolic control, and durable functional improvements.

Integrating Chiropractic Care Into An Anti-Inflammatory Care Plan

• Assessment: We evaluate spinal alignment, joint mobility, myofascial tension, and movement patterns. We correlate these with pain generation, stress load, and functional deficits.
• Adjustments: Gentle, precise chiropractic adjustments reduce joint restriction, lower pain signaling, and improve proprioception. This can decrease sympathetic arousal and encourage parasympathetic activity—an important step for immune balance.
• Soft Tissue and Neuromuscular Work: Targeted soft tissue therapies, neuromuscular re-education, and proprioceptive drills reduce aberrant tone and improve control, lowering injury risk during rehabilitation.
• Rehab Integration: We pair adjustments with individualized exercise to build durability and reinforce new movement patterns. This combination reduces recurrent nociceptive input and supports transition to M2-like tissue repair states.

With medical oversight from Dr. Cardenas, all interventions are executed with safety parameters, especially for patients with comorbidities or on complex medication regimens.

Medical Oversight: The Role Of Dr. Maria Guadalupe Cardenas, MD

Dr. Cardenas’ oversight adds a vital layer of safety and clinical competence:

• Diagnostics: Orders and interprets labs and imaging, monitors biomarkers (e.g., hs-CRP, lipid profile, fasting insulin), and evaluates comorbidities.
• Medication Management: Ensures chiropractic and functional interventions align with current prescriptions and helps taper or escalate medications appropriately in collaboration with patients’ primary or specialty clinicians.
• Risk Assessment: Screens for red flags, vascular risks, neurologic deficits, and systemic conditions that require prioritization or referral.
• Care Coordination: Facilitates referrals to cardiology, neurology, rheumatology, or behavioral health when indicated.

This model ensures our integrative strategies align with medical standards and that patient safety remains paramount.

Functional Medicine Lens: Layering Interventions For Lasting Change

Functional medicine provides a structured framework for investigating root drivers and building tiered interventions:

• History and Systems Mapping: We map timelines of stressors, infections, injuries, dietary shifts, sleep disruption, and environmental exposures.
• Testing: When indicated, we use targeted labs to refine interventions rather than over-test. We prefer markers that influence actionable steps.
• Phased Plan:

• • Phase 1: Stabilize—sleep, breathing, gentle movement, core nutrition.
  • Phase 2: Build—strength, aerobic capacity, mobility, targeted nutrients.
  • Phase 3: Resolve—fine-tune inflammatory drivers, address stubborn triggers.
  • Phase 4: Sustain—maintenance routines, periodic re-evaluation.

The aim is not maximalism but precision—introducing the least invasive, most impactful steps first.

Personal Injury And Acute Care: Reducing Inflammation While Healing

Acute injuries ignite M1-driven responses. Our acute-phase care:

• Protects and Loads: Correct bracing, controlled loading to prevent disuse atrophy.
• Reduces Nociception: Early chiropractic care, gentle mobilization, and soft tissue work limit central sensitization.
• Optimizes Rebuild: Progressive rehab to preserve range of motion and strength.
• Nutrition: Adequate protein, omega-3s, and anti-inflammatory foods to fuel repair without compromising early inflammatory phases necessary for healing.

We balance necessary inflammation with timely resolution to minimize the risk of chronic pain.

A Realistic Pathway To Immune Balance

• Set Expectations: Resolution is a process. Most patients need 8–12 weeks for early shifts and 6–12 months for durable changes.
• Measure What Matters: We watch function, pain, HRV, sleep quality, and select labs to mark progress.
• Relapse Planning: Stressful life events can reignite inflammation; we build relapse plans to maintain gains.
• Collaboration: Communication between patient, chiropractor, physician, and any specialists is essential.

Our approach is pragmatic: make the next right change, consistently.

Safety Considerations

• We avoid one-size-fits-all supplements or protocols.
• We closely monitor patients with significant comorbidities under Dr. Cardenas’ oversight.
• We respect the role of conventional medications and avoid abrupt changes without coordinating care.
• We continuously reassess to ensure interventions remain appropriate.

Safety and personalization are our guardrails.

Final Thoughts: You Don’t Have Ten Problems—You Have One Dysregulated System Expressing Many Symptoms

Chronic, systemic inflammation is the common soil from which many chronic conditions grow. By focusing on resolution biology, immune regulation, autonomic balance, and mechanical integrity, we help patients reclaim function and resilience. Our multidisciplinary team—combining chiropractic, internal medicine, functional medicine, and rehabilitation—delivers a balanced, evidence-informed path that addresses the upstream drivers sustaining chronic disease.

If you’re ready to explore an integrated approach to your health, our team in El Paso is here to support you with compassionate, accountable care grounded in science.

References

• Calder, P. C. (2020). Nutrition, immunity and COVID-19. BMJ Nutrition, Prevention & Health.
• Emerging Risk Factors Collaboration. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality. Lancet.
• Emerging Risk Factors Collaboration. (2012). Interleukin-6 receptor pathways in coronary heart disease. Lancet.
• Esposito, K., et al. (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation.
• Franceschi, C., et al. (2018). Inflammaging and “garb-aging”. Trends in Endocrinology & Metabolism.
• Furman, D., et al. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine.
• Gleeson, M., et al. (2011). The anti-inflammatory effects of exercise. Nature Reviews Immunology.
• Heneka, M. T., et al. (2015). Neuroinflammation in Alzheimer’s disease. Lancet Neurology.
• Irwin, M. R. (2015). Why sleep is important for health. Nature Reviews Immunology.
• Josefowicz, S. Z., et al. (2012). Regulatory T cell mechanisms. Annual Review of Immunology.
• Kaptoge, S., et al. (2010). Interleukin-6 and risk of coronary heart disease. Lancet.
• Kaptoge, S., et al. (2014). Association of C-reactive protein with risk of coronary heart disease. Journal of the American Medical Association.
• Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016). From dietary fiber to host physiology: short-chain fatty acids. Cell.
• Panahi, Y., et al. (2016). Curcuminoids and inflammatory markers. Phytotherapy Research.
• Ridker, P. M., et al. (2017). Anti-inflammatory therapy with canakinumab for atherosclerotic disease. New England Journal of Medicine.
• Salter, M. W., & Stevens, B. (2017). Microglia emerge as central players. Nature Medicine.
• Sakaguchi, S., et al. (2008). Regulatory T cells and immune tolerance. Cell.
• Schwartz, M., & Baruch, K. (2014). The immune system and the brain. Trends in Immunology.
• Serhan, C. N., & Levy, B. D. (2018). Resolvins in inflammation resolution. Cold Spring Harbor Perspectives in Biology.
• Tracey, K. J. (2002). The inflammatory reflex. Nature.

SEO tags: systemic inflammation, macrophages M1 M2, microglia neuroinflammation, regulatory T cells Tregs, integrative chiropractic care, internal medicine oversight, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso Texas chiropractor, functional medicine, rehabilitation, autonomic nervous system, HRV vagal tone, omega-3 SPMs, inflammaging, IL-6 TNF-alpha, BDNF neuroplasticity, personal injury care, multidisciplinary clinic, Dr Maria Guadalupe Cardenas MD, Dr Alex Jimenez DC